Youfu Luo

505 total citations
21 papers, 428 citations indexed

About

Youfu Luo is a scholar working on Molecular Biology, Organic Chemistry and Rehabilitation. According to data from OpenAlex, Youfu Luo has authored 21 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Rehabilitation. Recurrent topics in Youfu Luo's work include Magnolia and Illicium research (6 papers), Oxidative Organic Chemistry Reactions (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). Youfu Luo is often cited by papers focused on Magnolia and Illicium research (6 papers), Oxidative Organic Chemistry Reactions (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). Youfu Luo collaborates with scholars based in China, Switzerland and Netherlands. Youfu Luo's co-authors include Yuquan Wei, Lijuan Chen, Yinghua Ma, Huaqing Cui, Qinghua Cui, Dali Yin, Wei Zhu, Zhizhi Chen, Woo Shik Shin and Jing Tian and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Bacteriology and Journal of Medicinal Chemistry.

In The Last Decade

Youfu Luo

21 papers receiving 427 citations

Peers

Youfu Luo
Se-Jung Lee South Korea
Youfu Luo
Citations per year, relative to Youfu Luo Youfu Luo (= 1×) peers Se-Jung Lee

Countries citing papers authored by Youfu Luo

Since Specialization
Citations

This map shows the geographic impact of Youfu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youfu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youfu Luo more than expected).

Fields of papers citing papers by Youfu Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youfu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youfu Luo. The network helps show where Youfu Luo may publish in the future.

Co-authorship network of co-authors of Youfu Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Youfu Luo. A scholar is included among the top collaborators of Youfu Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youfu Luo. Youfu Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Zhiqiang, Yang Yang, Qiantao Wang, et al.. (2024). Integrating computational and experimental approaches in discovery and validation of MmpL3 pore domain inhibitors for specific labelling of Mycobacterium tuberculosis. International Journal of Biological Macromolecules. 279(Pt 2). 135212–135212. 1 indexed citations
2.
Xu, Xin, et al.. (2023). Targeting caseinolytic protease P and its AAA1 chaperone for tuberculosis treatment. Drug Discovery Today. 28(3). 103508–103508. 5 indexed citations
3.
Fan, Dongmei, et al.. (2023). Repurposing TAK875 as a novel STAT3 inhibitor for treating inflammatory bowel disease. Biochemical Pharmacology. 219. 115957–115957. 5 indexed citations
4.
Ju, Yuan, Qi An, Yiwen Zhang, et al.. (2021). Recent advances in Clp protease modulation to address virulence, resistance and persistence of MRSA infection. Drug Discovery Today. 26(9). 2190–2197. 28 indexed citations
5.
Luo, Youfu, et al.. (2018). [Exposure to disinfection by-products during gestation and newborns' small for gestational age].. PubMed. 52(9). 885–891. 3 indexed citations
6.
Liu, Xue, Jing Li, Zhixing Feng, et al.. (2017). Transcriptional Repressor PtvR Regulates Phenotypic Tolerance to Vancomycin in Streptococcus pneumoniae. Journal of Bacteriology. 199(14). 19 indexed citations
7.
Zhao, Yinglan, et al.. (2017). Synthesis, Crystal Structure and Antitumour Activity Evaluation of 1H-thieno[2,3-c]chromen-4(2H)-one Derivatives. Journal of Chemical Research. 41(1). 36–41. 3 indexed citations
8.
Liu, Jing, Dan Sun, Jinfeng He, et al.. (2016). Gastroprotective effects of several H2RAs on ibuprofen-induced gastric ulcer in rats. Life Sciences. 149. 65–71. 19 indexed citations
9.
Gong, Chen, Yuan Ju, Tao Yang, et al.. (2015). Natural amino acid salt catalyzed aldol reactions of isatins with ketones: highly enantioselective construction of 3-alkyl-3-hydroxyindolin-2-ones. Tetrahedron Asymmetry. 26(17). 943–947. 17 indexed citations
10.
Fan, Rangrang, Yuelong Wang, Bo Han, et al.. (2014). Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis. International Journal of Biological Macromolecules. 69. 100–107. 18 indexed citations
11.
Cui, Qinghua, Woo Shik Shin, Youfu Luo, et al.. (2013). Thymidylate Kinase: An Old Topic Brings New Perspectives. Current Medicinal Chemistry. 20(10). 1286–1305. 52 indexed citations
12.
Zhu, Wei, Afu Fu, Jia Hu, et al.. (2011). 5-Formylhonokiol exerts anti-angiogenesis activityviainactivating the ERK signaling pathway. Experimental & Molecular Medicine. 43(3). 146–146. 21 indexed citations
14.
Wang, Guangcheng, Hao Zheng, Zhizhi Chen, et al.. (2011). (Z)-5-(4-Methoxybenzylidene)thiazolidine-2,4-dione, a Novel Readily Available and Orally Active Glitazone, Attenuates the Bleomycin-Induced Pulmonary Fibrosis in Vivo. Biological and Pharmaceutical Bulletin. 34(2). 219–225. 5 indexed citations
16.
Ma, Yinghua, Xianhuo Wang, Xiaohua Wu, et al.. (2010). (Z)-5-(4-methoxybenzylidene) thiazolidine-2, 4-dione ameliorates the adjuvant-induced arthritis via inhibiting the migration of macrophage and down-regulating the cytokine mRNA expression. International Immunopharmacology. 10(11). 1456–1462. 19 indexed citations
17.
Wei, Xin, Jing Han, Zhizhi Chen, et al.. (2010). A phosphoinositide 3-kinase-γ inhibitor, AS605240 prevents bleomycin-induced pulmonary fibrosis in rats. Biochemical and Biophysical Research Communications. 397(2). 311–317. 50 indexed citations
18.
Peng, Xiaodong, Wu Xiao-Hua, Lijuan Chen, et al.. (2009). Inhibition of Phosphoinositide 3-Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice. Journal of Pharmacology and Experimental Therapeutics. 332(1). 46–56. 54 indexed citations
19.
Luo, Youfu, Yongbin Xu, Lijuan Chen, et al.. (2009). Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol. Bioorganic & Medicinal Chemistry Letters. 19(16). 4702–4705. 20 indexed citations
20.
Luo, Youfu, Yongbin Xu, Lijuan Chen, et al.. (2007). Preparative purification of anti-tumor derivatives of honokiol by high-speed counter-current chromatography. Journal of Chromatography A. 1178(1-2). 160–165. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026